Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"TOYO Pharmaceutical","sponsor":"PharmaMar","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Taiwan Toyo Obtains Exclusive License for New Soft Tissue Sarcoma Drug Yondelis\u00ae in Taiwan, Hong Kong and Macau","therapeuticArea":"Oncology","highestDevelopmentStatus":"Approved","country":"JAPAN","productType":"Small molecule","productStatus":"Approved","date":"June 2020","url1":"","url2":"","graph1":"Oncology","graph2":"Approved"}]

    Find Clinical Drug Pipeline Developments & Deals by TOYO Pharmaceutical

    Menu

    TOYO Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              TOYO Pharmaceutical

              Contact Supplier
              • Deals
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag Japan
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Taiwan Toyo Obtains Exclusive License for New Soft Tissue Sarcoma Drug Yondelis® in Taiwan, Hong Kong and Macau

              Details:

              Under the agreement, Taiwan Toyo will distribute the new anti-cancer drug Yondelis (trabectedin), a newly synthesized anti-tumor drug derived from the sea squirt Ecteinascidia turbinata, in Taiwan, Hong Kong and Macau.

              Lead Product(s): Trabectedin

              Therapeutic Area: Oncology Product Name: Yondelis

              Highest Development Status: Approved Product Type: Small molecule

              Recipient: PharmaMar

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Licensing Agreement June 09, 2020

              ASK
              US
              PHARMACOMPASS
              Upload
              your Pipeline Activity
              Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.
              Temad- We think of world-class quality.
              Post Enquiry
              POST ENQUIRY